Outcomes in meningitis/ventriculitis treated with intravenous or intraventricular plus intravenous colistin

Acta Neurochirurgica

Volumn 158, Issue 3, 2016, Pages 603-610

  Fotakopoulos, George ^a,c   Makris, Demosthenes ^b   Chatzi, Maria ^b   Tsimitrea, Eleni ^b   Zakynthinos, Epaminondas ^b   Fountas, Kostas ^a  

^a UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

^c NONE   (Greece)

Author keywords

CNS infections; Intrathecal intraventricular colistin treatment; Nosocomial meningitis ventriculitis

Indexed keywords

COLISTIMETHATE; ANTIINFECTIVE AGENT; COLISTIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; ANASTOMOSIS; ANTIBIOTIC RESISTANCE; ARTICLE; BRAIN VENTRICULITIS; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; DRUG ADMINISTRATION; DRUG DOSE REDUCTION; EXTERNAL VENTRICULAR DRAINAGE RELATED FEVER; FEMALE; FEVER; HUMAN; INTRAVENTRICULAR DRUG ADMINISTRATION; KIDNEY FAILURE; LENGTH OF STAY; MALE; MENINGITIS; MIDDLE AGED; MORTALITY; MORTALITY RATE; NEUROSURGERY; NOSOCOMIAL MENINGITIS; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TREATMENT DURATION; TREATMENT RESPONSE; ACINETOBACTER INFECTIONS; CEREBRAL VENTRICULITIS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MENINGITIS, BACTERIAL;

ACINETOBACTER INFECTIONS; ADMINISTRATION, INTRAVENOUS; ADULT; ANTI-BACTERIAL AGENTS; CEREBRAL VENTRICULITIS; COLISTIN; FEMALE; HUMANS; INJECTIONS, INTRAVENTRICULAR; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED;

EID: 84958115278     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-016-2702-y     Document Type: Article

References (40)

1. Alfahad WA, Omrani AS (2014) Update on colistin in clinical practice. Saudi Med J 35(1):9–19
2. Baiocchi M, Catena V, Zago S, Badolati L, Baccarin M (2010) Intrathecal colistin for treatment of multidrug resistant (MDR) Pseudomonas aeruginosa after neurosurgical ventriculitis. Infez Med 18(3):182–6
3. Bargiacchi O, Rossati A, Car P, Brustia D, Brondolo R, Rosa F, Garavelli PL, De Rosa FG (2014) Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram-negative bacteria: case reports and review. Infection 42(5):801–9
4. Blount JP, Campbell JA, Haines SJ (1993) Complications in ventricular cerebrospinal fluid shunting. Neurosurg Clin N Am 4:633–656
5. Camacho EF, Boszczowski I, Basso M, Jeng BC, Freire MP, Guimarães T, Teixeira MJ, Costa SF (2011) Infection rate and risk factors associated with infections related to external ventricular drain. Infection 39(1):47–51
6. Cascio A, Conti A, Sinardi L, Iaria C, Angileri FF, Stassi G, David T, Versaci A, Iaria M, David A (2010) Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature. Int J Infect Dis 14(7):e572–9
7. Chatzi M, Karvouniaris M, Makris D, Tsimitrea E, Gatos C, Tasiou A, Mantzarlis K, Fountas KN, Zakynthinos E (2014) Bundle of measures for external cerebral ventricular drainage-associated ventriculitis. Crit Care Med 42(1):66–73
8. De Bonis P, Lofrese G, Scoppettuolo G, Spanu T, Cultrera R, Labonia M, Cavallo MA, Mangiola A, Anile C, Pompucci A (2015) Intraventricular versus intravenous colistin for the treatment of extensively drug-resistant Acinetobacter baumannii meningitis. Eur J Neurol 31
9. Faillace WJ (1995) A no-touch technique protocol to diminish cerebrospinal fluid shunt infection. Surg Neurol 43:344–350
10. Falagas MSKK (2006) Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 10:R27
11. Falagas ME, Kasiakou SK (2006) Use of international units when dosing colistin will help decrease confusion related to various formulations of the drug around the world. Antimicrob Agents Chemother 50:2274–2275
12. Fernandez-Viladrich P, Corbella X, Corral L, Tubau F, Mateu A (1999) Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium. Clin Infect Dis 28:916–7
13. Gobin P, Lemaître F, Marchand S, Couet W, Olivier JC (2010) Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography-tandem mass spectrometry. Antimicrob Agents Chemother 54(5):1941–8
14. Goodwin NJ (1969) Colistin sulfate versus sodium colistimethate. Ann Intern Med 70(1):232–3
15. Henwood CJ, Gatward T, Warner M et al (2002) Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936). J Antimicrob Chemother 49:479–87
16. Hoeprich PD (1970) The polymyxins. Med Clin North Am 54:1257–65
17. Karaiskos I, Galani L, Baziaka F, Giamarellou H (2013) Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review. Int J Antimicrob Agents 41(6):499–508
18. Katragkou A, Roilides E (2005) Successful treatment of multi drug-resistant Acinetobacter baumannii central nervous system infections with colistin. J Clin Microbiol 43:4916–4917
19. Khawcharoenporn T, Apisarnthanarak A, Mundy LM (2010) Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review. Clin Microbiol Infect 16(7):888–94
20. Kim BN, Peleg AY, Lodise TP, Lipman J, Li J, Nation R, Paterson DL (2009) Management of meningitis due to antibiotic-resistant Acinetobacter species. Lancet Infect Dis 9(4):245–55
21. Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE (1970) Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med 72:857–868
22. Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, Paterson DL (2006) Colistin: the reemerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis 6:589–601
23. Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES Jr (2008) Ventriculostomy-related infections: a critical review of the literature. Neurosurgery 62:688–700
24. Markantonis SL, Markou N, Fousteri M, Sakellaridis N, Karatzas S, Alamanos I, Dimopoulou E, Baltopoulos G (2009) Penetration of colistin into cerebrospinal fluid. Antimicrob Agents Chemother 53:4907–4910
25. McClelland S 3rd, Hall WA (2007) Postoperative central nervous system infection: incidence and associated factors in 2111 neurosurgical procedures. Clin Infect Dis 45:55–59
26. McGirt MJ, Zaas A, Fuchs HE, George TM, Kaye K, Sexton DJ (2003) Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis 36:858–862
27. Munoz-Price LS, Weinstein RA (2008) Acinetobacter infection. N Engl J Med 20;358(12):1271-81. Review
28. Nation RL, Li J, Cars O, Couet W, Dudley MN, Kaye KS, Mouton JM, Paterson DL, Tam VH, Theuretzbacher U, Tsuji BT, Turnidje JD (2013) Consistent global approach on reporting of colistin doses to promote safe and effective use. Clin Infect Dis 58:139–141
29. Ng J, Gosbell IB, Kelly JA, Boyle MJ, Ferguson JK (2006) Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review. J Antimicrob Chemother 58(5):1078–81
30. Nseir S, Favory R, Jozefowicz E, Decamps F, Dewavrin F, Brunin G, Di Pompeo C, Mathieu D, Durocher A (2008) VAT Study Group. Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study. Crit Care 12(3):R62
31. Remeš F, Tomáš R, Jindrák V, Vaniš V, Setlík M (2013) Intraventricular and lumbar intrathecal administration of antibiotics in postneurosurgical patients with meningitis and/or ventriculitis in a serious clinical state. J Neurosurg 119(6):1596–602
32. Rodriguez Guardado A, Blanco A, Asensi V, Pérez F, Rial JC, Pintado V, Bustillo E, Lantero M, Tenza E, Alvarez M, Maradona JA, Carton JA (2008) Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother 61(4):908–13
33. Scheithauer S, Bürgel U, Ryang YM, Haase G, Schiefer J, Koch S, Häfner H, Lemmen S (2009) Prospective surveillance of drain associated meningitis/ventriculitis in a neurosurgery and neurological intensive care unit. Neurol Neurosurg Psychiatry 80(12):1381–5
34. Laxmi S, Tunkel AR (2011) Healthcare-associated bacterial meningitis. Curr Infect Dis Rep 13:367–373
35. Stenehjem E, Armstrong WS (2012) Central nervous system device infections. Infect Dis Clin North Am 26:89–110
36. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ (2004) Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39:1267–84
37. Vicari G, Bauer SR, Neuner EA, Lam SW (2013) Association between colistin dose and microbiologic outcomes in patients with multidrug-resistant Gram-negative bacteremia. Clin Infect Dis 56:398–404
38. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K (2009) EPIC II group of investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323–9
39. Wang JH, Lin PC, Chou CH, Ho CM, Lin KH, Tsai CT, Wang JH, Chi CY, Ho MW (2014) Intraventricular antimicrobial therapy in postneurosurgical Gram-negative bacillary meningitis or ventriculitis: a hospital-based retrospective study. J Microbiol Immunol Infect 47(3):204–10
40. Ziaka M, Markantonis SL, Fousteri M, Zygoulis P, Panidis D, Karvouniaris M, Makris D, Zakynthinos E (2013) Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection. Antimicrob Agents Chemother 57(4):1938–40